HK inno.N aims to double sales over the next three years: CEO
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
During his first interview with Maeil Business Newspaper since the company¡¯s Kosdaq debut last month, Kang said flagship products in the two business divisions will drive the sales target achievement based on additional market launches and aggressive marketing.
HK inno.N achieved 598.4 billion won in sales last year, with 517.2 billion won from ETC and 81.2 billion won from HB&B.
Key sales drivers in ETC include Kcab (tegoprazan), a gastroesophageal reflux disease drug. Kcab, which was independently developed by HK inno.N and launched as the country¡¯s 30th novel drug in 2019, generated sales of 81.1 billion won in the Korean market alone last year.
Kang said Kcab sales will increase fast with two-digit royalty payments expected from a new formulation launch of the drug in China next year, in addition to more market penetration into Latin American and Southeast Asian countries in the near future.
The drug is currently under Phase 1 clinical trials in the United States. Other promising drugs in the pipeline include an autoimmune disease drug and a non-alcoholic steatohepatitis (NASH) drug. The R&D team is also working to develop a Covid-19 vaccine.
The company is planning aggressive marketing for its parenteral nutrition products. Kang said. HK inno.N makes up about 30 percent of the local parenteral nutrition market, closely chasing No. 1 player with about 35 percent and it aims to catch up by 2024.
The company is developing a new total parenteral nutrition (TPN) product that contains essential nutrients in one bag for intravenous delivery. HK inno.N generated 86 billion won in sales last year from 44 parenteral nutrition brands. Last year, a new production line was added to roll out a total of 100 million parenteral nutrition products a year, the largest capacity in the bag-type product sector in Korea.
[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- HK inno.N aims to double sales over the next three years: CEO - Pulse by Maeil Business News Korea
- Local asset managers buy new logistics center in Goyang to be leased to CJ Logistics - Pulse by Maeil Business News Korea
- Korean Inc. normalizing capex from 2023 in bigger scope than pre-pandemic times: survey - Pulse by Maeil Business News Korea
- Seoul readies to counter UK steel safeguard by ending concession - Pulse by Maeil Business News Korea
- Korean sea carriers may avoid massive fine for rigging under revised shipping act - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 이재명 사법 리스크에 정치권 ‘동상이몽’ [신율의 정치 읽기]
- 은퇴 암시했던 보아, 팬들과 소통 재개… ‘데뷔 24주년 점핑이들과 함께’ - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이